Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in hu...
Guardado en:
Autores principales: | Pauline Chaste, Nathalie Clement, Oriane Mercati, Jean-Luc Guillaume, Richard Delorme, Hany Goubran Botros, Cécile Pagan, Samuel Périvier, Isabelle Scheid, Gudrun Nygren, Henrik Anckarsäter, Maria Rastam, Ola Ståhlberg, Carina Gillberg, Emilie Serrano, Nathalie Lemière, Jean Marie Launay, Marie Christine Mouren-Simeoni, Marion Leboyer, Christopher Gillberg, Ralf Jockers, Thomas Bourgeron |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db5bfbc334f143c8acb3c470126be6b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Variations of the candidate SEZ6L2 gene on Chromosome 16p11.2 in patients with autism spectrum disorders and in human populations.
por: Marina Konyukh, et al.
Publicado: (2011) -
Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders
por: Cécile Pagan, et al.
Publicado: (2017) -
Heterogeneous pattern of selective pressure for PRRT2 in human populations, but no association with autism spectrum disorders.
por: Guillaume Huguet, et al.
Publicado: (2014) -
Experiences Of Immigrant Parents In Sweden Participating In A Community Assessment And Intervention Program For Preschool Children With Autism
por: Nilses Å, et al.
Publicado: (2019) -
Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?
por: Manuel Schiff, et al.
Publicado: (2011)